Tabula Rasa HealthCare Competitors

Tabula Rasa HealthCare (NASDAQ:TRHC) and MultiPlan (NYSE:MPLN) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Valuation & Earnings

This table compares Tabula Rasa HealthCare and MultiPlan's revenue, earnings per share (EPS) and valuation.

MultiPlan has lower revenue, but higher earnings than Tabula Rasa HealthCare.

Analyst Ratings

This is a summary of current ratings and price targets for Tabula Rasa HealthCare and MultiPlan, as provided by MarketBeat.

Tabula Rasa HealthCare presently has a consensus target price of $52.20, suggesting a potential upside of 20.95%. MultiPlan has a consensus target price of $9.25, suggesting a potential upside of 48.00%. Given MultiPlan's stronger consensus rating and higher probable upside, analysts clearly believe MultiPlan is more favorable than Tabula Rasa HealthCare.

Insider and Institutional Ownership

0.1% of MultiPlan shares are owned by institutional investors. 11.6% of Tabula Rasa HealthCare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Tabula Rasa HealthCare and MultiPlan's net margins, return on equity and return on assets.

Summary

MultiPlan beats Tabula Rasa HealthCare on 6 of the 8 factors compared between the two stocks.

Tabula Rasa HealthCare (NASDAQ:TRHC) and American Well (NYSE:AMWL) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Valuation & Earnings

This table compares Tabula Rasa HealthCare and American Well's revenue, earnings per share (EPS) and valuation.

American Well has lower revenue, but higher earnings than Tabula Rasa HealthCare.

Analyst Ratings

This is a summary of current ratings and price targets for Tabula Rasa HealthCare and American Well, as provided by MarketBeat.

Tabula Rasa HealthCare presently has a consensus target price of $52.20, suggesting a potential upside of 20.95%. American Well has a consensus target price of $33.25, suggesting a potential upside of 93.99%. Given American Well's stronger consensus rating and higher probable upside, analysts clearly believe American Well is more favorable than Tabula Rasa HealthCare.

Insider and Institutional Ownership

19.0% of American Well shares are owned by institutional investors. 11.6% of Tabula Rasa HealthCare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Tabula Rasa HealthCare and American Well's net margins, return on equity and return on assets.

Summary

American Well beats Tabula Rasa HealthCare on 7 of the 9 factors compared between the two stocks.

Tabula Rasa HealthCare (NASDAQ:TRHC) and Envestnet (NYSE:ENV) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Valuation & Earnings

This table compares Tabula Rasa HealthCare and Envestnet's revenue, earnings per share (EPS) and valuation.

Envestnet has higher revenue and earnings than Tabula Rasa HealthCare. Tabula Rasa HealthCare is trading at a lower price-to-earnings ratio than Envestnet, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and price targets for Tabula Rasa HealthCare and Envestnet, as provided by MarketBeat.

Tabula Rasa HealthCare presently has a consensus target price of $52.20, suggesting a potential upside of 20.95%. Envestnet has a consensus target price of $87.20, suggesting a potential upside of 16.73%. Given Tabula Rasa HealthCare's higher probable upside, research analysts clearly believe Tabula Rasa HealthCare is more favorable than Envestnet.

Risk and Volatility

Tabula Rasa HealthCare has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500. Comparatively, Envestnet has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500.

Profitability

This table compares Tabula Rasa HealthCare and Envestnet's net margins, return on equity and return on assets.

Summary

Envestnet beats Tabula Rasa HealthCare on 11 of the 13 factors compared between the two stocks.

Tabula Rasa HealthCare (NASDAQ:TRHC) and Stamps.com (NASDAQ:STMP) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Valuation & Earnings

This table compares Tabula Rasa HealthCare and Stamps.com's revenue, earnings per share (EPS) and valuation.

Stamps.com has higher revenue and earnings than Tabula Rasa HealthCare. Tabula Rasa HealthCare is trading at a lower price-to-earnings ratio than Stamps.com, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and price targets for Tabula Rasa HealthCare and Stamps.com, as provided by MarketBeat.

Tabula Rasa HealthCare presently has a consensus target price of $52.20, suggesting a potential upside of 20.95%. Stamps.com has a consensus target price of $260.00, suggesting a potential upside of 26.43%. Given Stamps.com's stronger consensus rating and higher probable upside, analysts clearly believe Stamps.com is more favorable than Tabula Rasa HealthCare.

Risk and Volatility

Tabula Rasa HealthCare has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, Stamps.com has a beta of 0.4, indicating that its share price is 60% less volatile than the S&P 500.

Insider and Institutional Ownership

88.2% of Stamps.com shares are owned by institutional investors. 11.6% of Tabula Rasa HealthCare shares are owned by insiders. Comparatively, 9.6% of Stamps.com shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Tabula Rasa HealthCare and Stamps.com's net margins, return on equity and return on assets.

Summary

Stamps.com beats Tabula Rasa HealthCare on 11 of the 14 factors compared between the two stocks.

Tabula Rasa HealthCare (NASDAQ:TRHC) and WNS (NYSE:WNS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Valuation & Earnings

This table compares Tabula Rasa HealthCare and WNS's revenue, earnings per share (EPS) and valuation.

WNS has higher revenue and earnings than Tabula Rasa HealthCare. Tabula Rasa HealthCare is trading at a lower price-to-earnings ratio than WNS, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and price targets for Tabula Rasa HealthCare and WNS, as provided by MarketBeat.

Tabula Rasa HealthCare presently has a consensus target price of $52.20, suggesting a potential upside of 20.95%. WNS has a consensus target price of $76.30, suggesting a potential upside of 5.39%. Given Tabula Rasa HealthCare's higher probable upside, research analysts clearly believe Tabula Rasa HealthCare is more favorable than WNS.

Risk and Volatility

Tabula Rasa HealthCare has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, WNS has a beta of 1.43, indicating that its share price is 43% more volatile than the S&P 500.

Insider and Institutional Ownership

99.7% of WNS shares are owned by institutional investors. 11.6% of Tabula Rasa HealthCare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Tabula Rasa HealthCare and WNS's net margins, return on equity and return on assets.

Summary

WNS beats Tabula Rasa HealthCare on 12 of the 14 factors compared between the two stocks.

Tabula Rasa HealthCare (NASDAQ:TRHC) and HMS (NASDAQ:HMSY) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Valuation & Earnings

This table compares Tabula Rasa HealthCare and HMS's revenue, earnings per share (EPS) and valuation.

HMS has higher revenue and earnings than Tabula Rasa HealthCare. Tabula Rasa HealthCare is trading at a lower price-to-earnings ratio than HMS, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and price targets for Tabula Rasa HealthCare and HMS, as provided by MarketBeat.

Tabula Rasa HealthCare presently has a consensus target price of $52.20, suggesting a potential upside of 20.95%. HMS has a consensus target price of $34.25, suggesting a potential downside of 7.37%. Given Tabula Rasa HealthCare's stronger consensus rating and higher probable upside, research analysts clearly believe Tabula Rasa HealthCare is more favorable than HMS.

Risk and Volatility

Tabula Rasa HealthCare has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, HMS has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500.

Insider and Institutional Ownership

95.8% of HMS shares are owned by institutional investors. 11.6% of Tabula Rasa HealthCare shares are owned by insiders. Comparatively, 2.7% of HMS shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Tabula Rasa HealthCare and HMS's net margins, return on equity and return on assets.

Summary

HMS beats Tabula Rasa HealthCare on 9 of the 14 factors compared between the two stocks.